# Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome

> **NCT02595346** · PHASE2 · TERMINATED · sponsor: **University Hospital, Rouen** · enrollment: 25 (actual)

## Conditions studied

- Antiphospholipid Syndrome (APS)

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02595346
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-17
- **Primary completion:** 2020-08-05
- **Final completion:** 2020-08-05
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Difficulty in enrolling new patients
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595346, "Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02595346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*